ReP USP - Resultado da busca

Artigo de periodico
Ticagrelor versus clopidogrel after fibrinolytic therapy in patients with ST-elevation myocardial infarction: rationale and design of the ticagrelor in patients with ST-elevation myocardial infarction treated with thrombolysis (TREAT) trial (2018)
Berwanger, Otavio; Nicolau, José Carlos
Source: American heart journal. Unidade: FM
Subjects: FÁRMACOS (SISTEMA CARDIOVASCULAR), INFARTO DO MIOCÁRDIO, SÍNDROME CORONARIANA AGUDA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BERWANGER, Otavio e NICOLAU, José Carlos. Ticagrelor versus clopidogrel after fibrinolytic therapy in patients with ST-elevation myocardial infarction: rationale and design of the ticagrelor in patients with ST-elevation myocardial infarction treated with thrombolysis (TREAT) trial. American heart journal, v. 202, p. 89-96, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.ahj.2018.02.017. Acesso em: 08 maio 2024.
APA
Berwanger, O., & Nicolau, J. C. (2018). Ticagrelor versus clopidogrel after fibrinolytic therapy in patients with ST-elevation myocardial infarction: rationale and design of the ticagrelor in patients with ST-elevation myocardial infarction treated with thrombolysis (TREAT) trial. American heart journal, 202, 89-96. doi:10.1016/j.ahj.2018.02.017
NLM
Berwanger O, Nicolau JC. Ticagrelor versus clopidogrel after fibrinolytic therapy in patients with ST-elevation myocardial infarction: rationale and design of the ticagrelor in patients with ST-elevation myocardial infarction treated with thrombolysis (TREAT) trial [Internet]. American heart journal. 2018 ; 202 89-96.[citado 2024 maio 08 ] Available from: https://doi.org/10.1016/j.ahj.2018.02.017
Vancouver
Berwanger O, Nicolau JC. Ticagrelor versus clopidogrel after fibrinolytic therapy in patients with ST-elevation myocardial infarction: rationale and design of the ticagrelor in patients with ST-elevation myocardial infarction treated with thrombolysis (TREAT) trial [Internet]. American heart journal. 2018 ; 202 89-96.[citado 2024 maio 08 ] Available from: https://doi.org/10.1016/j.ahj.2018.02.017
Artigo de periodico
Cortical and subcortical brain morphometry differences between patients with autism spectrum disorder and healthy individuals across the lifespan: results from the ENIGMA ASD working group (2018)
Rooij, Daan van; Busatto Filho, Geraldo
Source: American journal of psychiatry. Unidade: FM
Subjects: ADOLESCENTES, CRIANÇAS, HIPOCAMPO, AMÍGDALA DO CEREBELO, IMAGEM POR RESSONÂNCIA MAGNÉTICA, AUTISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROOIJ, Daan van e BUSATTO FILHO, Geraldo. Cortical and subcortical brain morphometry differences between patients with autism spectrum disorder and healthy individuals across the lifespan: results from the ENIGMA ASD working group. American journal of psychiatry, v. 175, n. 4, p. 359-369, 2018Tradução . . Disponível em: https://doi.org/10.1176/appi.ajp.2017.17010100. Acesso em: 08 maio 2024.
APA
Rooij, D. van, & Busatto Filho, G. (2018). Cortical and subcortical brain morphometry differences between patients with autism spectrum disorder and healthy individuals across the lifespan: results from the ENIGMA ASD working group. American journal of psychiatry, 175( 4), 359-369. doi:10.1176/appi.ajp.2017.17010100
NLM
Rooij D van, Busatto Filho G. Cortical and subcortical brain morphometry differences between patients with autism spectrum disorder and healthy individuals across the lifespan: results from the ENIGMA ASD working group [Internet]. American journal of psychiatry. 2018 ; 175( 4): 359-369.[citado 2024 maio 08 ] Available from: https://doi.org/10.1176/appi.ajp.2017.17010100
Vancouver
Rooij D van, Busatto Filho G. Cortical and subcortical brain morphometry differences between patients with autism spectrum disorder and healthy individuals across the lifespan: results from the ENIGMA ASD working group [Internet]. American journal of psychiatry. 2018 ; 175( 4): 359-369.[citado 2024 maio 08 ] Available from: https://doi.org/10.1176/appi.ajp.2017.17010100
Artigo de periodico
Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) (2018)
Vallejo-vaz, Antonio J; Santos Filho, Raul Dias dos
Source: Atherosclerosis. Unidade: FM
Subjects: HIPERCOLESTEROLEMIA, COOPERAÇÃO INTERNACIONAL, MÉTODOS EPIDEMIOLÓGICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VALLEJO-VAZ, Antonio J e SANTOS FILHO, Raul Dias dos. Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC). Atherosclerosis, v. 277, p. 234-255, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2018.08.051. Acesso em: 08 maio 2024.
APA
Vallejo-vaz, A. J., & Santos Filho, R. D. dos. (2018). Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC). Atherosclerosis, 277, 234-255. doi:10.1016/j.atherosclerosis.2018.08.051
NLM
Vallejo-vaz AJ, Santos Filho RD dos. Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) [Internet]. Atherosclerosis. 2018 ; 277 234-255.[citado 2024 maio 08 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2018.08.051
Vancouver
Vallejo-vaz AJ, Santos Filho RD dos. Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) [Internet]. Atherosclerosis. 2018 ; 277 234-255.[citado 2024 maio 08 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2018.08.051
Artigo de periodico
World Heart Federation Cholesterol Roadmap (2017)
Murphy, A.; Santos Filho, Raul Dias dos
Source: Global heart. Unidade: FM
Subjects: COLESTEROL, DOENÇAS CARDIOVASCULARES, POLÍTICAS PÚBLICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MURPHY, A. e SANTOS FILHO, Raul Dias dos. World Heart Federation Cholesterol Roadmap. Global heart, v. 12, n. 3, p. 179-197.e5, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.gheart.2017.03.002. Acesso em: 08 maio 2024.
APA
Murphy, A., & Santos Filho, R. D. dos. (2017). World Heart Federation Cholesterol Roadmap. Global heart, 12( 3), 179-197.e5. doi:10.1016/j.gheart.2017.03.002
NLM
Murphy A, Santos Filho RD dos. World Heart Federation Cholesterol Roadmap [Internet]. Global heart. 2017 ; 12( 3): 179-197.e5.[citado 2024 maio 08 ] Available from: https://doi.org/10.1016/j.gheart.2017.03.002
Vancouver
Murphy A, Santos Filho RD dos. World Heart Federation Cholesterol Roadmap [Internet]. Global heart. 2017 ; 12( 3): 179-197.e5.[citado 2024 maio 08 ] Available from: https://doi.org/10.1016/j.gheart.2017.03.002

USP Schools

ReP

Filtros

Authors

Subjects

Funding Agencies